Tumor Evolution Driving Genome Instability, Immune Interactions, and Response to Radiotherapy

Area of Science:

• Oncology
• Immunology
• Radiation Oncology

Background:

• Tumor evolution and genomic instability are influenced by the immune system.
• Cancer cells adapt and grow by navigating immune surveillance and evasion.
• Advances in immunotherapy and radiotherapy prompt exploration of combination strategies.

Purpose of the Study:

• To review the role of immuno-radiotherapy in the context of cancer genome instability and tumor evolution.
• To discuss how genomic instability and tumor evolution impact immune surveillance and evasion.
• To explore recent preclinical and clinical studies of combined immunotherapy and radiotherapy.

Main Methods:

• Literature review of foundational studies on genomic instability and tumor evolution.
• Analysis of the interplay between cancer evolution and immune responses.
• Synthesis of recent preclinical and clinical data on immuno-radiotherapy.

Main Results:

• Genomic changes in tumors can promote adaptation and growth while potentially triggering immune responses.
• The balance between tumor evolution and the immune system presents opportunities and challenges for combination therapies.
• Understanding cancer evolution within the immune context is crucial for developing effective treatments.

Conclusions:

• Immuno-radiotherapy holds promise for overcoming treatment resistance by targeting cancer's evolutionary dynamics.
• Identifying ideal patient populations for combination therapy requires a deeper understanding of tumor-immune interactions.
• Further research into cancer evolution and immune evasion is essential for advancing therapeutic strategies.